Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SFOSF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$4$2$4$5
Dep. & Amort.$3$3$2$2
Deferred Tax$0$0-$0-$4
Stock-Based Comp.$0$0$0$0
Change in WC-$1-$1-$1$0
Other Non-Cash-$1-$0-$1$1
Operating Cash Flow$4$3$4$4
Investing Activities
PP&E Inv.-$4-$5-$6-$5
Net Acquisitions-$0-$1-$0$0
Inv. Purchases-$1-$1-$2-$1
Inv. Sales/Matur.$1$3$5$2
Other Inv. Act.$0-$0-$1-$0
Investing Cash Flow-$4-$5-$4-$4
Financing Activities
Debt Repay.$0$2$4$2
Stock Issued$0$0$0$0
Stock Repurch.-$0$0$0$0
Dividends Paid-$2-$2-$1-$1
Other Fin. Act.$1-$1$5-$1
Financing Cash Flow-$1-$1$4-$1
Forex Effect$0$0$0-$0
Net Chg. in Cash-$0-$2$5-$1
Supplemental Information
Beg. Cash$10$11$6$7
End Cash$9$10$11$6
Free Cash Flow$0-$2-$2-$1